1H-indole-3-glyoxylamide sPLA2 inhibitors
US6433001B1 · kind B1 · utility
1Cited by
19References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2000 |
| Grant date | Aug 13, 2002 |
| Priority date | — |
| Expiry date | Nov 16, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of novel 1H-indole-3-glyoxylamides is disclosed together with the use of such indole compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.